PSK condemns secret recording of former DP Gachagua at pharmacy

PSK condemns secret recording of former DP Gachagua at pharmacy

File image of Former Deputy President Rigathi Gachagua.

Vocalize Pre-Player Loader

Audio By Vocalize

The Pharmaceutical Society of Kenya (PSK) has condemned the unauthorised recording and circulation of a video showing former Deputy President Rigathi Gachagua purchasing medicine at a pharmacy, describing it as a serious violation of patient privacy and healthcare confidentiality.

In an official statement, PSK emphasised that pharmacies are healthcare environments where every individual is entitled to dignity, discretion, and protection of personal health information. 

“Recording any client within a pharmacy setting without consent constitutes a serious breach of privacy and healthcare confidentiality,” said Dr Wairimu Mbogo, PSK President.

The society noted that it is currently verifying the licensing status of professionals present at the pharmacy in question to determine if any regulatory action is warranted.

“This incident underscores the critical importance of ensuring that pharmacy outlets operate under the supervision of qualified and licensed professionals who understand and uphold ethical standards,” PSK said. “The presence of properly trained healthcare personnel is essential in safeguarding patient confidentiality, maintaining public trust, and preserving the integrity of the healthcare system.”

PSK further highlighted that pharmacists undergo advanced university training in pharmacology, therapeutics, clinical decision-making, and patient safety, and are bound by a professional oath to prioritise patient welfare, uphold confidentiality, and promote the safe use of medicines.

“Regardless of public profile or status, every Kenyan has the right to confidential healthcare,” said Dr Mbogo. 

Tags:

Rigathi Gachagua Pharmaceutical Society of Kenya

Want to send us a story? SMS to 25170 or WhatsApp 0743570000 or Submit on Citizen Digital or email wananchi@royalmedia.co.ke

Leave a Comment

Comments

No comments yet.